Re: VICTOZA - Taspoglutide
sharmam said:
Hello All
I have been told today of a new once a week injection for T2 diabetes, Taspoglutide is in phase 3 of the trials and is manufactured by Roche - has anyone else heard about this injection - I have been told it beats byetta and victoza - I have been on victoza 1.2 for two weeks now and I am very pleased with the results for me, much better than byetta as I suffered with sickness all the time. I would be interested if anyone else has heard of the new once weekly injection? and if anyone has had any bad side effects on 1.8 victoza.
the light and the end of the tunnel - we all hope.
Happy health everyone
We have known of this trial since 2008 when the Phase III Clinical Trials started. It will be some time before it ever gets the go ahead. As with all drugs everything takes time......here is a Press Release about the latest stage of progress.
Thursday 17th December 2009
Roche has announced the results of two T-emerge phase III trials of taspoglutide, a once-weekly glucagon-like peptide-1 therapy for patients with diabetes. It emerged from research by Ipsen.
T-emerge 5 tested subcutaneous weekly taspoglutide as an add-on to metformin in patients not responding to metformin and sulfonylurea. T-emerge 7 was a similar test for patients with high body-mass indices.
Roche reports that the treatment was generally well tolerated in both studies, the most frequently reported adverse reactions being nausea and vomiting.
Taspoglutide is similar to the natural hormone GLP-1, which has a key role in blood-sugar regulation. Substitutes that stimulate insulin and suppress glucagon are regarded as true innovations.
Copyright Press Association 2009
The data shows that taspoglutide is a promising once weekly treatment for patients with type 2 diabetes mellitus no longer controlled on oral antidiabetic medications," said lead author, Professor Michael Nauck, Head of the Diabeteszentrum Bad Lauterberg, Germany. "Like improved glucose control, drug-induced weight loss is particularly beneficial for this type of patient. We will wait to see the Phase III results with interest."
We certainly have no further data which states if it is any better than Byetta or Victoza......most drug companies always say it is better than x or y drug etc......I think I will wait and see.